Building a 6-Item Hand Eczema Symptom Diary With Trial Data
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Why this study is useful
This paper asks a focused question about work, daily activity or measurement. Keeping the population, denominator, design and timepoint visible prevents a useful result from becoming an exaggerated promise.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | Adults with chronic hand eczema in qualitative interviews, a phase-2b trial and the first 280 phase-3 treatment-phase completers |
| Design | Patient-reported-outcome development and psychometric validation |
| Timepoint | Daily seven-day averages across 16-week trial assessments |
| Key result | The final six items had Cronbach alpha 0.96 and ICC above 0.89; concurrent correlations were 0.53–0.64 and a four-point seven-day-average improvement was proposed as meaningful |
What the numbers mean
The final six items had Cronbach alpha 0.96 and ICC above 0.89; concurrent correlations were 0.53–0.64 and a four-point seven-day-average improvement was proposed as meaningful.
Important limitation: Validation used clinical-trial samples, the diary measures reported symptoms rather than objective signs, and a measurement threshold is not a treatment-effect guarantee.
Questionnaires, examinations, photographs, patch tests and administrative records answer different questions. A screening result can guide the next step, but it does not diagnose the cause of one person’s rash. An association can identify a pattern worth investigating, but it does not prove that a single task, material or personal factor caused every event.
Practical questions for a busy life
- What exposure happens before symptoms: water, soap, gloves, friction, heat, dust, resin, adhesive or another material?
- Which body sites are involved, and does the distribution match the suspected task or equipment?
- What should be tracked: visible severity, sleep, daily function, missed work, presenteeism or safe participation?
- Would occupational-health review, clinician examination or clinician-directed patch testing change the plan?
- What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain or major loss of function?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 38485862
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.